Sphingosine 1-phosphate antagonizes the effect of all-trans retinoic acid (ATRA) in a human colon cancer cell line by modulation of RARβ expression

Cancer Letters

Volumn 319, Issue 2, 2012, Pages 182-189

  Sun, De Fu ^a,b   Gao, Zu Hua ^c   Liu, Hui Ping ^a   Yuan, Yi ^a   Qu, Xian Jun ^a  

^a SHANDONG UNIVERSITY   (China)

^b YANTAI UNIVERSITY   (China)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

All trans retinoic acid (ATRA); HT 29 cells; Retinoid acid receptor (RAR ); Retinoids; Sphingosine 1 phosphate (S1P); SphK2

Indexed keywords

PROTEASOME; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 2;

ARTICLE; CANCER CELL; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL PROLIFERATION; COLONIC NEOPLASMS; DOWN-REGULATION; HT29 CELLS; HUMANS; LEUPEPTINS; LYSOPHOSPHOLIPIDS; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, RETINOIC ACID; SPHINGOSINE; TRETINOIN;

EID: 84862815076     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.01.012     Document Type: Article

References (39)

1. Lotan R. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochem. Biophys. Acta 1980, 605:33-91.
2. Costa S.L., Paillaud E., Fages C., Rochette-Egly C., Plassat J.L., Jouault H., Perzelova A., Tardy M. Effects of a novel synthetic retinoid on malignant glioma in vitro: inhibition of cell proliferation, induction of apoptosis and differentiation. Eur. J. Cancer 2001, 37:520-530.
3. Soprano D.R., Qin P., Soprano K.J. Retinoic acid receptors and cancers. Annu. Rev. Nutr. 2004, 24:201-221.
4. Bastien J., Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid target genes. Gene 2004, 328:1-16.
5. Gronemeyer H., Gustafsson J.A., Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat. Rev. Drug Discov. 2004, 3:950-964.
6. Altucci L., Gronemeyer H. The promise of retinoids to fight against cancer. Nat. Rev. Cancer 2001, 1:181-193.
7. Christov K. The novel RARbeta isoform (beta5) is a potential target of retinoids in breast cancer. Curr. Cancer Drug Targets 2009, 9:142-147.
8. Liu X., Nugoli M., Laferrière J., Saleh S.M., Rodrigue-Gervais I.G., Saleh M., Park M., Hallett M.T., Muller W.J., Giguère V. Stromal retinoic acid receptor beta promotes mammary gland tumorigenesis. Proc. Natl. Acad. Sci. USA 2011, 108:774-779.
9. Song S., Guan B., Men T., Hoque A., Lotan R., Xu X.C. Antitumor effect of retinoic acid receptor-beta2 associated with suppression of cyclooxygenase-2. Cancer Prev. Res. (Phila) 2009, 2:274-280.
10. de Thé H., Vivanco-Ruiz M.M., Tiollais P., Stunnenberg H., Dejean A. Identification of a retinoic acid responsive element in the retinoic acid receptor β gene. Nature 1990, 343:177-180.
11. McGregor F., Wagner E., Felix D., Soutar D., Parkinson K., Harrison P.R. Inappropriate retinoic acid receptor-beta expression in oral dysplasias: correlation with acquisition of the immortal phenotype. Cancer Res. 1997, 57:3886-3889.
12. Ren M., Pozzi S., Bistulfi G., Somenzi G., Rossetti S., Sacchi N. Impaired retinoic acid (RA) signal leads to RARbeta2 epigenetic silencing and RA resistance. Mol. Cell Biol. 2005, 25:10591-10603.
13. Geradts J., Chen J.Y., Russell E.K., Yankaskas J.R., Nieves L., Minna J.D. Human lung cancer cell lines exhibit resistance to retinoic acid treatment. Cell Growth Differ. 1993, 4:799-809.
14. Wu Q., Dawson M.I., Zheng Y., Hobbs P.D., Agadir A., Jong L., Li Y., Liu R., Lin B., Zhang X.K. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor selective retinoids. Mol. Cell Biol. 1997, 17:6598-6608.
15. Hla T., Lee M.J., Ancellin N., Liu C.H., Thangada S., Thompson B.D., Kluk M. Sphingosine-1-phosphate: extracellular mediator or intracellular second messenger?. Biochem. Pharmacol. 1999, 58:201-207.
16. B. Henry, C. Möller, M.T. Dimanche-Boitrel, E. Gulbins, K.A. Becker, Targeting the ceramide system in cancer, Cancer Lett. doi: . doi:10.1016/j.canlet.2011.07.010.
17. Lee M.J., Van Brocklyn J.R., Thangada S., Liu C.H., Hand A.R., Menzeleev R., Spiegel S., Hla T. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 1998, 279:1552-1555.
18. Malek R.L., Toman R.E., Edsall L.C., Wong S., Chiu J., Letterle C.A., Van Brocklyn J.R., Milstien S., Spiegel S., Lee N.H. Nrg-1 belongs to the endothelial differentiation gene family of G protein-coupled sphingosine-1-phosphate receptors. J. Biol. Chem. 2001, 276:5692-5699.
19. Hait N.C., Allegood J., Maceyka M., Strub G.M., Harikumar K.B., Singh S.K., Luo C., Marmorstein R., Kordula T., Milstien S., Spiegel S. Regulation of histone acetylation in the nucleus by Sphingosine-1-phosphate. Science 2009, 325:1254-1257.
20. Alvarez S.E., Harikumar K.B., Hait N.C., Allegood J., Strub G.M., Kim E.Y., Maceyka M., Jiang H., Luo C., Kordula T., Milstien S., Spiegel S. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 2009, 465:1084-1088.
21. Melendez A.J., Carlos-Dias E., Gosink M., Allen J.M., Takacs L. Human sphingosine kinase: molecular cloning, functional characterization and tissue distribution. Gene 2000, 251:19-26.
22. Liu H., Sugiura M., Nava V.E., Edsall L.C., Kono K., Poulton S., Milstien S., Kohama T., Spiegel S. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J. Biol. Chem. 2000, 275:19513-19520.
23. Dayon A., Brizuela L., Martin C., Mazerolles C., Pirot N., Doumerc N., Nogueira L., Golzio M., Teissié J., Serre G., Rischmann P., Malavaud B., Cuvillier O. Sphingosine kinase-1 is central to androgen-regulated prostate cancer growth and survival. PLoS. One 2009, 4:e8048.
24. Sukocheva O., Wang L., Verrier E., Vadas M.A., Xia P. Restoring endocrine response in breast cancer cells by inhibition of the sphingosine kinase-1 signaling pathway. Endocrinology 2009, 150:4484-4492.
25. Kohno M., Momoi M., Oo M.L., Paik J.H., Lee Y.M., Venkataraman K., Ai Y., Ristimaki A.P., Fyrst H., Sano H., Rosenberg D., Saba J.D., Proia R.L., Hla T. Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation. Mol. Cell Biol. 2006, 26:7211-7223.
26. Takeshita A., Watanabe A., Takada Y., Hanazawa S. Selective stimulation by ceramide of the expression of the a isoform of retinoic acid and retinoid X receptors in osteoblastic cells. J. Biol. Chem. 2000, 275:32220-32226.
27. Illuzzi G., Bernacchioni C., Aureli M., Prioni S., Frera G., Donati C., Valsecchi M., Chigorno V., Bruni P., Sonnino S., Prinetti A. Sphingosine kinase mediates resistance to the synthetic retinoid N-(4-hydroxyphenyl) retinamide in human ovarian cancer cells. J. Biol. Chem. 2010, 285:18594-18602.
28. Ding G., Sonoda H., Yu H., Kajimoto T., Goparaju S.K., Jahangeer S., Okada T., Nakamura S. Protein kinase D-mediated phosphorylation and nuclear export of sphingosine kinase 2. J. Biol. Chem. 2007, 282:27493-27502.
29. Kurie J.M., Buck J., Eppinger T.M., Moy D., Dmitrovsky E. 9-cis and all-trans retinoic acid induce a similar phenotype in human teratocarcinoma cells. Differentiation 1993, 54:123-129.
30. Bartolini G., Ammar K., Mantovani B., Scanabissi F., Ferreri A.M., Rocchi P., Orlandi M. Retinoids and cancer: antitumor effect of ATRA and of a new derivative of retinoic acid, IIF, on colon carcinoma cell lines CaCo-2 and HT-29. Anticancer Res. 2004, 24:1779-1783.
31. Cory A.H., Owen T.C., Barltrop J.A., Cory J.G. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 1991, 3:207-212.
32. Song S., Lippman S.M., Zou Y., Ye X., Ajani J.A., Xu X.C. Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-beta 2 expression. Oncogene 2005, 24:8268-8276.
33. Nava V.E., Cuvillier O., Edsall L.C., Kimura K., Milstien S., Gelmann E.P., Spiegel S. Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells. Cancer Res. 2000, 60:4468-4474.
34. Igarashi N., Okada T., Hayashi S., Fujita T., Jahangeer S., Nakamura S. Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis. J. Biol. Chem. 2003, 278:46832-46839.
35. French K.J., Schrecengost R.S., Lee B.D., Zhuang Y., Smith S.N., Eberly J.L., Yun J.K., Smith C.D. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res. 2003, 63:5962-5969.
36. Pchejetski D., Golzio M., Bonhoure E., Calvet C., Doumerc N., Garcia V., Mazerolles C., Rischmann P., Teissié J., Malavaud B., Cuvillier O. Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. Cancer Res. 2005, 65:11667-11675.
37. Dennis A.P., Haq R.U., Nawaz Z. Importance of the regulation of nuclear receptor degradation. Front Biosci. 2001, 6:D954-959.
38. Zhu J., Gianni M., Kopf E., Honoré N., Chelbi-Alix M., Koken M., Quignon F., Rochette-Egly C., de Thé H. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins. Proc. Natl. Acad. Sci. USA 1999, 96:14807-14812.
39. De los Santos M., Zambrano A., Sánchez-Pacheco A., Aranda A. Histone deacetylase inhibitors regulate RARβ expression in neuroblastoma cells by both transcriptional and posttranscriptional mechanisms. Mol. Endocrinol. 2007, 21:2416-2426.